Select your Market
{{ userContent.title }}
Results of Q1 2023
Forecast for fiscal 2023
| Q1 2023 | Change (in %, compared to Q1 2022) | Organic growth (in %, compared to Q1 2022) |
|---|---|---|---|
Group net sales | 5.3 | 1.8 | 0.8 |
EBITDA pre | 1.6 | -2.6 | -1.7 |
Life Science sales | 2.5 | 1.7 | 0.6 |
Healthcare sales | 1.9 | 6.2 | 5.3 |
Electronics sales | 0.9 | -5.9 | -7.1 |
2023 will be a transition year for us. But our structural growth drivers remain intact.
Overview by CFO Marcus Kuhnert
Detailed information about our business in the first quarter of 2023.
Downloads for the Media
Additional Downloads
The conference call for the media and the conference call for analysts are available as a recording.
Press Releases
Merck KGaA, Darmstadt, Germany generated net sales of € 5.3 billion in the first quarter of 2023. This corresponds to an increase of 1.8% over the year-earlier quarter (organically 0.8%).
2023/05/11
Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more
